David B. MacLean - Concepedia

Author

David B. MacLean

Also Known As

B J Fleming, Cynthia A. Wong, D B Maclean, D. B. MACLEAN, D. B. MacLean, D. B. Maclean, D. MacLean, D. Maclean, D.B. MACLEAN, D.B. MacLean

328

Publications

6.2K

Citations

H-Index

151

Concepts

All Affiliations

McMaster University Wake Forest University Rhode Island Hospital Pfizer (United States)

About

David B. MacLean is an author at McMaster University specializing in medicine, pharmacology, and biochemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	28	54	2.2K
2	Natural Sciences	25	72	1.7K
3	Engineering	20	38	1K
4	Health Sciences	8	8	470
5	Public Health	1	1	28

David B. MacLean

148

Publications

Citations

H-Index

Page 1

	Year	Citations
Effects of an Oral Growth Hormone Secretagogue in Older Adults Heidi K. White, Charles D. Petrie, William Landschulz, The Journal of Clinical Endocrinology & Metabolism	2009	169
Phytoecdysteroids Increase Protein Synthesis in Skeletal Muscle Cells Jonathan Gorelick-Feldman, David B. MacLean, Nebojša Ilić, Journal of Agricultural and Food Chemistry Skeletal Muscle CellsMuscle FunctionEngineeringCytoskeletonRat Grip Strength	2008	161
Effect of an NK1 receptor antagonist (CP-99,994) on hypertonic saline-induced bronchoconstriction and cough in male asthmatic subjects. John V. Fahy, Hofer Wong, Pierangelo Geppetti, American Journal of Respiratory and Critical Care Medicine AsthmaNk1 Receptor AntagonistMale Asthmatic SubjectsMild AsthmaAllergy	1995	142
Increased ATP content/production in the hypothalamus may be a signal for energy-sensing of satiety: studies of the anorectic mechanism of a plant steroidal glycoside David B. MacLean, LuGuang Luo Brain Research Anorectic MechanismNeuroendocrine MechanismHypothalamic PeptideMetabolic StateHealth Sciences	2004	141
Orteronel plus prednisone in patients with chemotherapy-naive metastatic castration-resistant prostate cancer (ELM-PC 4): a double-blind, multicentre, phase 3, randomised, placebo-controlled trial Fred Saad, Karim Fizazi, Viorel Jinga, The Lancet Oncology UrologyOncologyGenitourinary CancerMedicineClinical Trials	2015	122
Quantitative and qualitative assessment of closed fracture healing using computed tomography and conventional radiography1 Mikayel Grigoryan, J.A. Lynch, Anke Fierlinger, Academic Radiology Skeletal TraumaQualitative AssessmentHealth SciencesMedical ImagingSurgical Stabilization	2003	116
The substance P receptor antagonist CP-99,994 reduces acute postoperative pain* Raymond A. Dionne, Mitchell B. Max, Sharon M. Gordon, Clinical Pharmacology & Therapeutics	1998	110
Structural studies on the polysaccharide portion of "A-band" lipopolysaccharide from a mutant (AK1401) of <i>Pseudomonas</i> <i>aeruginosa</i> strain PAO1 Todd L. Arsenault, Donald W. Hughes, David B. MacLean, Canadian Journal of Chemistry Gram-negative BacteriologyBiochemistryMedicineMicrobial ProteomicsBacteriology	1991	109
Growth Hormone Administration and Exercise Effects on Muscle Fiber Type and Diameter in Moderately Frail Older People James V. Hennessey, Joseph A. Chromiak, Shirley Dellaventura, Journal of the American Geriatrics Society	2001	100
Substance P (Neurokinin-1) Antagonist Prevents Postoperative Vomiting after Abdominal Hysterectomy Procedures Zsuzsanna Gesztesi, Phillip E. Scuderi, Paul F. White, Anesthesiology	2000	95

Page 1